ARTICLE | Top Story
Sanofi unveils global reorganization
July 16, 2015 1:19 AM UTC
Sanofi (Euronext:SAN; NYSE:SNY) said it will reorganize the company into five global business units. The realignment is Sanofi's first major move since Olivier Brandicourt took over as CEO in April.
The company will create three new global business units: General Medicines and Emerging Markets; Specialty Care, also known as Sanofi Genzyme; and Diabetes and Cardiovascular. Two existing units, vaccine business Sanofi Pasteur and animal health unit Merial, will remain intact. The new structure will take effect Jan. 1, 2016. ...